Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 255

1.

Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages.

Cole LE, Shirey KA, Barry E, Santiago A, Rallabhandi P, Elkins KL, Puche AC, Michalek SM, Vogel SN.

Infect Immun. 2007 Aug;75(8):4127-37. Epub 2007 May 21.

2.

Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain.

Medina EA, Morris IR, Berton MT.

J Immunol. 2010 Dec 15;185(12):7562-72. doi: 10.4049/jimmunol.0903790. Epub 2010 Nov 22.

3.

Macrophage proinflammatory response to Francisella tularensis live vaccine strain requires coordination of multiple signaling pathways.

Cole LE, Santiago A, Barry E, Kang TJ, Shirey KA, Roberts ZJ, Elkins KL, Cross AS, Vogel SN.

J Immunol. 2008 May 15;180(10):6885-91.

4.
5.

TLR-dependent control of Francisella tularensis infection and host inflammatory responses.

Abplanalp AL, Morris IR, Parida BK, Teale JM, Berton MT.

PLoS One. 2009 Nov 20;4(11):e7920. doi: 10.1371/journal.pone.0007920.

6.

Role of TLR signaling in Francisella tularensis-LPS-induced, antibody-mediated protection against Francisella tularensis challenge.

Cole LE, Mann BJ, Shirey KA, Richard K, Yang Y, Gearhart PJ, Chesko KL, Viscardi RM, Vogel SN.

J Leukoc Biol. 2011 Oct;90(4):787-97. doi: 10.1189/jlb.0111014. Epub 2011 Jul 12.

7.

Phagosomal retention of Francisella tularensis results in TIRAP/Mal-independent TLR2 signaling.

Cole LE, Laird MH, Seekatz A, Santiago A, Jiang Z, Barry E, Shirey KA, Fitzgerald KA, Vogel SN.

J Leukoc Biol. 2010 Feb;87(2):275-81. doi: 10.1189/jlb.0909619. Epub 2009 Nov 4.

8.

Immunologic consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity.

Cole LE, Elkins KL, Michalek SM, Qureshi N, Eaton LJ, Rallabhandi P, Cuesta N, Vogel SN.

J Immunol. 2006 Jun 1;176(11):6888-99.

9.

Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.

Okan NA, Chalabaev S, Kim TH, Fink A, Ross RA, Kasper DL.

MBio. 2013 Feb 12;4(1):e00638-12. doi: 10.1128/mBio.00638-12.

10.

Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes.

Santiago AE, Cole LE, Franco A, Vogel SN, Levine MM, Barry EM.

Vaccine. 2009 Apr 21;27(18):2426-36. doi: 10.1016/j.vaccine.2009.02.073. Epub 2009 Mar 3.

11.

Models derived from in vitro analyses of spleen, liver, and lung leukocyte functions predict vaccine efficacy against the Francisella tularensis Live Vaccine Strain (LVS).

De Pascalis R, Chou AY, Ryden P, Kennett NJ, Sjöstedt A, Elkins KL.

MBio. 2014 Apr 8;5(2):e00936. doi: 10.1128/mBio.00936-13.

12.

Repression of inflammasome by Francisella tularensis during early stages of infection.

Dotson RJ, Rabadi SM, Westcott EL, Bradley S, Catlett SV, Banik S, Harton JA, Bakshi CS, Malik M.

J Biol Chem. 2013 Aug 16;288(33):23844-57. doi: 10.1074/jbc.M113.490086. Epub 2013 Jul 2.

13.

Toll-like receptor 2 is required for inflammatory responses to Francisella tularensis LVS.

Katz J, Zhang P, Martin M, Vogel SN, Michalek SM.

Infect Immun. 2006 May;74(5):2809-16.

14.
15.

Francisella tularensis live vaccine strain folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation.

Ulland TK, Janowski AM, Buchan BW, Faron M, Cassel SL, Jones BD, Sutterwala FS.

Infect Immun. 2013 Jan;81(1):201-8. doi: 10.1128/IAI.00991-12. Epub 2012 Oct 31.

16.

Differential expression of microRNAs in Francisella tularensis-infected human macrophages: miR-155-dependent downregulation of MyD88 inhibits the inflammatory response.

Bandyopadhyay S, Long ME, Allen LA.

PLoS One. 2014 Oct 8;9(10):e109525. doi: 10.1371/journal.pone.0109525. eCollection 2014.

17.

Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice.

Zhang P, Katz J, Michalek SM.

Mol Immunol. 2009 Feb;46(4):677-87. doi: 10.1016/j.molimm.2008.08.281. Epub 2008 Oct 17.

18.

Francisella tularensis LPS induces the production of cytokines in human monocytes and signals via Toll-like receptor 4 with much lower potency than E. coli LPS.

Dueñas AI, Aceves M, Orduña A, Díaz R, Sánchez Crespo M, García-Rodríguez C.

Int Immunol. 2006 May;18(5):785-95. Epub 2006 Mar 30.

PMID:
16574669
19.

Interleukin-17 protects against the Francisella tularensis live vaccine strain but not against a virulent F. tularensis type A strain.

Skyberg JA, Rollins MF, Samuel JW, Sutherland MD, Belisle JT, Pascual DW.

Infect Immun. 2013 Sep;81(9):3099-105. doi: 10.1128/IAI.00203-13. Epub 2013 Jun 17.

Supplemental Content

Support Center